Latest news with #Elbrus
Yahoo
27-04-2025
- Health
- Yahoo
Woman with terminal cancer to run Everest marathon
A woman with incurable breast cancer is preparing to travel to the Himalayas to take part in the world's highest marathon. Shaunna Burke, 49, from Addingham, West Yorkshire, had booked her place on the Everest Marathon in 2024, but was forced to delay her plans for a year after she was diagnosed with stage four breast cancer. The cancer had spread to her liver and in the past 12 months she underwent four months of chemotherapy, a double mastectomy, liver surgery and radiotherapy. Dr Burke, a keen mountaineer and associate professor in exercise and health psychology, said: "I approached my treatment like I was training for the hardest climb of my life." This will be her first marathon but not her first major summit. She has previously climbed four out of the seven highest peaks in the world - Mount Aconcagua in Argentina, Elbrus in Russia, Kilimanjaro in Africa and Everest in Nepal. Dr Burke has been to the Everest region three times before, first visiting back in 2003. "Before my diagnosis, I was training for the Everest Marathon and to do this climb," she said. "Then when the diagnosis struck my life, I took a sharp turn and I had to put a lot of short term plans on hold. "Long term plans became very uncertain and at the time of my diagnosis, I thought there might not be a chance that I could get back to Nepal. "There were some some very dark moments when I didn't know what I'd be facing," she said. Dr Burke became the second Canadian woman to summit Everest in 2005 and since then she has also researched the psychology of mountaineering, and the preparation needed for a huge climb like Everest. Dr Burke, whose work involves studying exercise and its effects on cancer, said throughout her cancer treatment she managed to stay fit, running to and from her hospital appointments as a way of coping. "Each time I had treatment, I ran from my house to the chemotherapy bus and parked my car further away from St James's Hospital so I could run three miles to radiotherapy," she said. "Staying active helped me to tolerate my treatment – I experienced few side effects, and it also helped me psychologically." As a researcher into the links between exercise and cancer, Dr Burke said in a surreal way she "applied her own research to her own life". She said: "I approached it with the mentality of a researcher in exercise and cancer. "I'm very familiar with how you get patients ready for treatment, whether that be surgery, chemotherapy or radiotherapy. "I developed my own 'prehabilitation' plan that was tailored to me, which not only involved exercise, but it also involved looking at a spectrum of elements that I could adapt that would help make my treatment as effective as possible. "That included reducing stress as much as much as I possibly could, ensuring that I had a healthy diet, and then exercise being paramount to to my training plan." As well as running outdoors, Dr Burke has been training at the OTE Performance Centre and Altitude Chamber in Leeds. Her work at the University of Leeds, which has been supported by funders including Macmillan, Yorkshire Cancer Research and Cancer Research UK, have shown that people should keep as active as possible before and during treatment to aid recovery. The Tenzing Hillary Everest Marathon is an annual race which starts at Everest Base Camp and finishes in the town of Namche Bazaar. It is held on 29 May to celebrate the Everest ascent by Tenzing Norgay Sherpa and Sir Edmund Hillary on the same date in 1953. Dr Burke is due to travel to Nepal on 15 May, as before the marathon she is to complete a 6,119 metre (20,075ft) climb of Lobuche Peak. The peak is a separate challenge within the Everest region, which requires technical climbing skills and high-altitude acclimatisation - something she hopes will help prepare her for the marathon. Dr Burke has so far raised more than £7,000 for cancer charity Macmillan, which helped her during her treatment at Airedale Hospital and St James' Hospital in Leeds. Lisa Martin, relationship fundraising lead for Macmillan, said: "This is a monumental challenge and we are behind Shaunna all the way. "We are so grateful that she has decided to donate the money raised to Macmillan, as whatever she raises will go a long way in providing vital support for people living with cancer. "Shaunna is so dedicated to this challenge and wish her all the very best of luck. Shaunna – thank you so much for supporting Macmillan." Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North. Veteran finishes Everest marathon in citrus outfit Deaf and blind marathon runner on track for Everest England to Everest - The triathlon to the top of the world Everest Marathon Macmillan Cancer Support University of Leeds
Yahoo
27-04-2025
- Health
- Yahoo
Woman with terminal cancer to run Everest marathon
A woman with incurable breast cancer is preparing to travel to the Himalayas to take part in the world's highest marathon. Shaunna Burke, 49, from Addingham, West Yorkshire, had booked her place on the Everest Marathon in 2024, but was forced to delay her plans for a year after she was diagnosed with stage four breast cancer. The cancer had spread to her liver and in the past 12 months she underwent four months of chemotherapy, a double mastectomy, liver surgery and radiotherapy. Dr Burke, a keen mountaineer and associate professor in exercise and health psychology, said: "I approached my treatment like I was training for the hardest climb of my life." This will be her first marathon but not her first major summit. She has previously climbed four out of the seven highest peaks in the world - Mount Aconcagua in Argentina, Elbrus in Russia, Kilimanjaro in Africa and Everest in Nepal. Dr Burke has been to the Everest region three times before, first visiting back in 2003. "Before my diagnosis, I was training for the Everest Marathon and to do this climb," she said. "Then when the diagnosis struck my life, I took a sharp turn and I had to put a lot of short term plans on hold. "Long term plans became very uncertain and at the time of my diagnosis, I thought there might not be a chance that I could get back to Nepal. "There were some some very dark moments when I didn't know what I'd be facing," she said. Dr Burke became the second Canadian woman to summit Everest in 2005 and since then she has also researched the psychology of mountaineering, and the preparation needed for a huge climb like Everest. Dr Burke, whose work involves studying exercise and its effects on cancer, said throughout her cancer treatment she managed to stay fit, running to and from her hospital appointments as a way of coping. "Each time I had treatment, I ran from my house to the chemotherapy bus and parked my car further away from St James's Hospital so I could run three miles to radiotherapy," she said. "Staying active helped me to tolerate my treatment – I experienced few side effects, and it also helped me psychologically." As a researcher into the links between exercise and cancer, Dr Burke said in a surreal way she "applied her own research to her own life". She said: "I approached it with the mentality of a researcher in exercise and cancer. "I'm very familiar with how you get patients ready for treatment, whether that be surgery, chemotherapy or radiotherapy. "I developed my own 'prehabilitation' plan that was tailored to me, which not only involved exercise, but it also involved looking at a spectrum of elements that I could adapt that would help make my treatment as effective as possible. "That included reducing stress as much as much as I possibly could, ensuring that I had a healthy diet, and then exercise being paramount to to my training plan." As well as running outdoors, Dr Burke has been training at the OTE Performance Centre and Altitude Chamber in Leeds. Her work at the University of Leeds, which has been supported by funders including Macmillan, Yorkshire Cancer Research and Cancer Research UK, have shown that people should keep as active as possible before and during treatment to aid recovery. The Tenzing Hillary Everest Marathon is an annual race which starts at Everest Base Camp and finishes in the town of Namche Bazaar. It is held on 29 May to celebrate the Everest ascent by Tenzing Norgay Sherpa and Sir Edmund Hillary on the same date in 1953. Dr Burke is due to travel to Nepal on 15 May, as before the marathon she is to complete a 6,119 metre (20,075ft) climb of Lobuche Peak. The peak is a separate challenge within the Everest region, which requires technical climbing skills and high-altitude acclimatisation - something she hopes will help prepare her for the marathon. Dr Burke has so far raised more than £7,000 for cancer charity Macmillan, which helped her during her treatment at Airedale Hospital and St James' Hospital in Leeds. Lisa Martin, relationship fundraising lead for Macmillan, said: "This is a monumental challenge and we are behind Shaunna all the way. "We are so grateful that she has decided to donate the money raised to Macmillan, as whatever she raises will go a long way in providing vital support for people living with cancer. "Shaunna is so dedicated to this challenge and wish her all the very best of luck. Shaunna – thank you so much for supporting Macmillan." Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North. Veteran finishes Everest marathon in citrus outfit Deaf and blind marathon runner on track for Everest England to Everest - The triathlon to the top of the world Everest Marathon Macmillan Cancer Support University of Leeds
BBC News
27-04-2025
- Health
- BBC News
Addingham woman with incurable cancer to run Everest marathon
A woman with incurable breast cancer is preparing to travel to the Himalayas to take part in the world's highest marathon. Shaunna Burke, 49, from Addingham, West Yorkshire, had booked her place on the Everest Marathon in 2024, but was forced to delay her plans for a year after she was diagnosed with stage four breast cancer. The cancer had spread to her liver and in the past 12 months she underwent four months of chemotherapy, a double mastectomy, liver surgery and Burke, a keen mountaineer and associate professor in exercise and health psychology, said: "I approached my treatment like I was training for the hardest climb of my life." This will be her first marathon but not her first major has previously climbed four out of the seven highest peaks in the world - Mount Aconcagua in Argentina, Elbrus in Russia, Kilimanjaro in Africa and Everest in Burke has been to the Everest region three times before, first visiting back in 2003."Before my diagnosis, I was training for the Everest Marathon and to do this climb," she said."Then when the diagnosis struck my life, I took a sharp turn and I had to put a lot of short term plans on hold. "Long term plans became very uncertain and at the time of my diagnosis, I thought there might not be a chance that I could get back to Nepal."There were some some very dark moments when I didn't know what I'd be facing," she Burke became the second Canadian woman to summit Everest in 2005 and since then she has also researched the psychology of mountaineering, and the preparation needed for a huge climb like Everest. Dr Burke, whose work involves studying exercise and its effects on cancer, said throughout her cancer treatment she managed to stay fit, running to and from her hospital appointments as a way of coping. "Each time I had treatment, I ran from my house to the chemotherapy bus and parked my car further away from St James's Hospital so I could run three miles to radiotherapy," she said. "Staying active helped me to tolerate my treatment – I experienced few side effects, and it also helped me psychologically."As a researcher into the links between exercise and cancer, Dr Burke said in a surreal way she "applied her own research to her own life".She said: "I approached it with the mentality of a researcher in exercise and cancer. "I'm very familiar with how you get patients ready for treatment, whether that be surgery, chemotherapy or radiotherapy."I developed my own 'prehabilitation' plan that was tailored to me, which not only involved exercise, but it also involved looking at a spectrum of elements that I could adapt that would help make my treatment as effective as possible. "That included reducing stress as much as much as I possibly could, ensuring that I had a healthy diet, and then exercise being paramount to to my training plan."As well as running outdoors, Dr Burke has been training at the OTE Performance Centre and Altitude Chamber in Leeds. Her work at the University of Leeds, which has been supported by funders including Macmillan, Yorkshire Cancer Research and Cancer Research UK, have shown that people should keep as active as possible before and during treatment to aid recovery. The Tenzing Hillary Everest Marathon is an annual race which starts at Everest Base Camp and finishes in the town of Namche Bazaar. It is held on 29 May to celebrate the Everest ascent by Tenzing Norgay Sherpa and Sir Edmund Hillary on the same date in Burke is due to travel to Nepal on 15 May, as before the marathon she is to complete a 6,119 metre (20,075ft) climb of Lobuche Peak. The peak is a separate challenge within the Everest region, which requires technical climbing skills and high-altitude acclimatisation - something she hopes will help prepare her for the marathon. Dr Burke has so far raised more than £7,000 for cancer charity Macmillan, which helped her during her treatment at Airedale Hospital and St James' Hospital in Leeds. Lisa Martin, relationship fundraising lead for Macmillan, said: "This is a monumental challenge and we are behind Shaunna all the way."We are so grateful that she has decided to donate the money raised to Macmillan, as whatever she raises will go a long way in providing vital support for people living with cancer."Shaunna is so dedicated to this challenge and wish her all the very best of luck. Shaunna – thank you so much for supporting Macmillan." Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Yahoo
24-04-2025
- Business
- Yahoo
Russia on track to manufacture 28nm chips in domestic fabs by 2030, 19 years after tech first debuted
When you buy through links on our articles, Future and its syndication partners may earn a commission. Despite all odds, Russia hopes to kick off local mass production of chips using its domestic 28nm-class process technology by 2030, just as it expected several years ago. This 28nm process technology will purportedly enable MCST, the developer of SPARC-based Elbrus processors, to build CPUs with performance that meets the expectations of Russian companies. However, some argue that the Elbrus ecosystem has to develop before the adoption of such processors becomes viable. "We hope that such fabs will emerge between 2028 and 2030," said Konstantin Trushkin, Deputy Director for Development at MCST, at an event in Moscow, according to ComNews (state affiliation unknown). "But we understand that we will not be able to manufacture processors based on Intel [x86] instruction set architecture, because no one will grant us the rights to do so. Therefore, processors with different ISAs — such as Elbrus — will be products at domestic fabs." Taiwanese authorities restricted the supply of more advanced chips to Russia and Belarus after Russia invaded Ukraine in early 2022, a move that coincided with Russia's efforts to revive its own semiconductor production sector. For now, the Russia-based fab has completed development of a lithography tool that can produce chips using a 350 nm-class fabrication process, although mass production has yet to commence. Additionally, ZNTC is developing a tool capable of a 130nm fabrication process, so it remains to be seen when Russian tools will be capable of a more advanced fabrication technology. However, Russia also reportedly smuggles ASML's PAS 5500-series systems, as well as spare parts for them, into the country. The most advanced versions of ASML's PAS 5500-series scanners, equipped with an ArF laser with a 193nm wavelength, can get to a resolution of 90nm (PAS 5500/1150C) and below. MCST expects to be the first to deliver a high-performance CPU from a domestic plant that meets the performance needs of Russian enterprises. Trushkin argued that relying on foreign CPUs poses unacceptable risks for national information systems, so the country needs to rely on domestic hardware (i.e., no Arm, no x86). He acknowledged that such a transition involves major obstacles, notably the need to port software to a new hardware environment. According to Trushkin, transitioning from x86 or Arm-based designs to alternatives like Elbrus involves addressing compatibility and optimization challenges. Another speaker, Dmitry Gusev of InfoTeKS, questioned the viability of Elbrus adoption. He recalled an earlier attempt roughly six or seven years ago to integrate Elbrus processors into his company's systems, which was abandoned due to a shortage of personnel able to adapt software for the ISA. At the time, no solution was available to resolve the skills gap. Gusev recommended a shift in focus toward building a supportive ecosystem around Elbrus through educational and institutional investments first, before deploying them for something more serious. Rather than enforcing adoption through regulatory pressure, he argued that the government should instead encourage universities and training centers to cultivate talent, so that companies would no longer be forced to compete for the same limited pool of qualified specialists in five to eight years.
